Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States

被引:20
|
作者
Meyers J. [1 ,4 ]
Classi P. [2 ]
Wietecha L. [3 ]
Candrilli S. [1 ,4 ]
机构
[1] RTI Health Solutions, Research Triangle Park, NC
[2] Eli Lilly and Company, Lilly Corporate Center, Indianapolis
[3] Lilly USA, LLC, Lilly Corporate Center, Indianapolis
[4] RTI Health Solutions, Research Triangle Park, NC
关键词
Primary Diagnosis; Oppositional Defiant Disorder; Control Child; Emotional Disturbance; Nationwide Inpatient Sample;
D O I
10.1186/1753-2000-4-31
中图分类号
学科分类号
摘要
Background: This retrospective database analysis used data from the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample (NIS) to examine common primary diagnoses among children and adolescents hospitalized with a secondary diagnosis of attention- deficit/hyperactivity disorder (ADHD) and assessed the burden of ADHD.Methods: Hospitalized children (aged 6-11 years) and adolescents (aged 12-17 years) with a secondary diagnosis of ADHD were identified. The 10 most common primary diagnoses (using the first 3 digits of the ICD-9-CM code) were reported for each age group. Patients with 1 of these conditions were selected to analyze demographics, length of stay (LOS), and costs. Control patients were selected if they had 1 of the 10 primary diagnoses and no secondary ADHD diagnosis. Patient and hospital characteristics were reported by cohort (i.e., patients with ADHD vs. controls), and LOS and costs were reported by primary diagnosis. Multivariable linear regression analyses were undertaken to adjust LOS and costs based on patient and hospital characteristics.Results: A total of 126,056 children and 204,176 adolescents were identified as having a secondary diagnosis of ADHD. Among children and adolescents with ADHD, the most common diagnoses tended to be mental health related (i.e., affective psychoses, emotional disturbances, conduct disturbances, depressive disorder, or adjustment reaction). Other common diagnoses included general symptoms, asthma (in children only), and acute appendicitis. Among patients with ADHD, a higher percentage were male, white, and covered by Medicaid. LOS and costs were higher among children with ADHD and a primary diagnosis of affective psychoses (by 0.61 days and $51), adjustment reaction (by 1.71 days and $940), or depressive disorder (by 0.41 days and $124) versus controls. LOS and costs were higher among adolescents with ADHD and a primary diagnosis of affective psychoses (by 1.04 days and $352), depressive disorder (by 0.94 days and $517), conduct disturbances (by 0.86 days and $1,330), emotional disturbances (by 1.45 days and $1,626), adjustment reaction (by 1.25 days and $702), and neurotic disorders (by 1.60 days and $541) versus controls.Conclusion: Clinicians and health care decision makers should be aware of the potential impact of ADHD on hospitalized children and adolescents. © 2010 Meyers et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States
    Gupte-Singh, Komal
    Singh, Rakesh R.
    Lawson, Kenneth A.
    VALUE IN HEALTH, 2017, 20 (04) : 602 - 609
  • [2] Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective
    Schein, Jeff
    Adler, Lenard A.
    Childress, Ann
    Gagnon-Sanschagrin, Patrick
    Davidson, Mikhail
    Kinkead, Frederic
    Cloutier, Martin
    Guerin, Annie
    Lefebvre, Patrick
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (02): : 168 - 179
  • [3] Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective
    Schein, Jeff
    Adler, Lenard A.
    Childress, Ann
    Cloutier, Martin
    Gagnon-Sanschagrin, Patrick
    Davidson, Mikhail
    Kinkead, Frederic
    Guerin, Annie
    Lefebvre, Patrick
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 193 - 205
  • [4] ECONOMIC BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) AMONG ADULTS IN THE UNITED STATES: A SOCIETAL PERSPECTIVE
    Adler, L. A.
    Childress, A.
    Cloutier, M.
    Gagnon-Sanschagrin, P.
    Davidson, M.
    Kinkead, F.
    Guerin, A.
    Lefebvre, P.
    Schein, J.
    VALUE IN HEALTH, 2021, 24 : S128 - S128
  • [5] BURDEN OF ILLNESS AND COMORBIDITIES IN ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Montejano, L. B.
    Sasane, R.
    Hodgkins, P.
    Huse, D.
    VALUE IN HEALTH, 2009, 12 (07) : A357 - A357
  • [6] ECONOMIC BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) AMONG CHILDREN AND ADOLESCENTS IN THE UNITED STATES (US): A SOCIETAL PERSPECTIVE
    Adler, L. A.
    Childress, A.
    Cloutier, M.
    Gagnon-Sanschagrin, P.
    Davidson, M.
    Kinkead, F.
    Guerin, A.
    Lefebvre, P.
    Schein, J.
    VALUE IN HEALTH, 2021, 24 : S6 - S7
  • [7] ATTENTION-DEFICIT DISORDER WITH HYPERACTIVITY AMONG PEDIATRIC OUTPATIENTS
    BHATIA, MS
    NIGAM, VR
    BOHRA, N
    MALIK, SC
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES, 1991, 32 (02): : 297 - 306
  • [8] ASSESSING THE ECONOMIC BURDEN AND HEALTH CARE UTILIZATION OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER AMONG MEDICAID PATIENTS IN THE UNITED STATES
    Zhang, Q.
    Zhao, Y.
    Keshishian, A.
    Xie, L.
    Yuce, H.
    Baser, O.
    VALUE IN HEALTH, 2016, 19 (03) : A187 - A187
  • [9] Global Economic Burden of Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Chhibber, Anindit
    Watanabe, Alexandre Hikiji
    Chaisai, Chayutthaphong
    Veettil, Sajesh K.
    Chaiyakunapruk, Nathorn
    PHARMACOECONOMICS, 2021, 39 (04) : 399 - 420
  • [10] Global Economic Burden of Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Anindit Chhibber
    Alexandre Hikiji Watanabe
    Chayutthaphong Chaisai
    Sajesh K. Veettil
    Nathorn Chaiyakunapruk
    PharmacoEconomics, 2021, 39 : 399 - 420